Response And Plasma Genotyping From Phase I/Ii Trial Of Ensartinib (X-396) In Patients (Pts) With Alk Plus Nsclc

JOURNAL OF THORACIC ONCOLOGY(2017)

引用 5|浏览18
暂无评分
关键词
Nextgen Sequencing,ALK,NSCLC
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要